Oct-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Avexia has demonstrated robust performance in the Illinois market, particularly in the Topical category, where it has consistently held the top position from July to October 2024. This consistent ranking is indicative of strong consumer preference and market penetration. In the Capsules category, Avexia maintained its second-place ranking, showcasing a steady demand for its products. Meanwhile, in the Concentrates category, Avexia showed a progressive climb, improving its ranking from 23rd in July to 15th by October, suggesting a growing consumer interest in this segment. However, the slight dip in sales for Capsules in October could be a point of concern that might require strategic attention to maintain its competitive edge.
In Massachusetts, Avexia's performance in the Concentrates category has been fluctuating, with rankings moving from 30th in July to 19th in August, then dropping to 27th by October. This inconsistency might indicate a volatile market or a need for a more targeted marketing strategy. The Topical category in Massachusetts saw Avexia drop out of the top 30 in September, which could be a critical area to address for sustained growth. In Maryland, Avexia's Topical products have shown remarkable growth, climbing to the number one spot by September and maintaining it in October, reflecting strong brand loyalty and product acceptance. The absence of rankings in the Concentrates category post-July in Maryland could suggest a potential area for improvement or a shift in market dynamics. Meanwhile, in Ohio, Avexia's Tincture & Sublingual category has seen a positive trend, moving up to the third position by October, indicating a strengthening foothold in this product segment.
Competitive Landscape
In the Illinois topical cannabis market, Avexia has consistently maintained its position as the top brand from July to October 2024, demonstrating a strong hold on the market despite fluctuations in sales. This stability in rank suggests a loyal customer base and effective brand strategies. In contrast, Doctor Solomon's has experienced some volatility, shifting between second and third place, indicating potential challenges in sustaining its market position. Meanwhile, Pure Essentials has remained in the fourth or fifth position, showing limited upward mobility in the rankings. The consistent top ranking of Avexia, coupled with its relatively stable sales figures, highlights its dominance in the Illinois topical category, suggesting that competitors may need to innovate or adjust their strategies to close the gap.
Notable Products
In October 2024, Avexia's top-performing product was the CBD/THC 1:1 Harmony Pain Relief Balm in the Topical category, maintaining its number one rank for four consecutive months with notable sales of 11,378. The CBD/THC 4:1 Relief Tablets in the Capsules category consistently held the second position, although its sales slightly decreased compared to September. The CBN/CBD/THC 1:1:1 Comfort Tablets also remained steady in third place, despite a drop in sales. The CBG/THC 1:1 Balance Tablets saw an improvement, moving up to fourth from fifth place, indicating a positive trend in consumer preference. Meanwhile, the CBD/THC 1:1 Harmony Micro-Dosed Tablets slipped to fifth, reflecting a slight decline in demand.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.